Search cutoffs
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Current report (Form 8-K) · Jun 12, 2026 · Leadership change · Item 5.07 · Financial statements
Xilio Therapeutics, Inc.
4
Leadership change
Jun 12, 2026
| ItemItem | Disclosure |
|---|---|
| Item 5.02 | Director or executive officer departure or appointment |
| Item 5.07 | Item 5.07 |
| Item 9.01 | Financial statements and exhibits |
Xilio Therapeutics, Inc. filed this to disclose a change in directors or executive officers appointments, departures, or role changes that can signal a strategic shift.
) 828 Winter Street , Suite 300 Waltham , Massachusetts 02451 (Address of Principal Executive Offices) (Zip Code) Registrant’s telephone number, including area code: (857) 524-2466 Not applicable (Former Name or Former Address, if Changed Since Last Report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A. below): ☐ Written communications pursuant to Rule 425 under th…
This filing reports Item 5.02 (director or executive officer departure or appointment). These item codes often precede or accompany restructuring, leadership changes, or deals that can shift headcount.
Xilio Therapeutics, Inc. reported material events that can affect workforce planning. cutoffs surfaces the filing alongside WARN layoffs, H-1B activity, and company signals.
